Cargando…

Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets

Thrombin activates platelets through protease activated receptors (PARs). Mouse platelets express PAR3 and PAR4. PAR3 does not signal in platelets. However, PAR4 is a relatively poor thrombin substrate and requires PAR3 as a cofactor at low thrombin concentrations. In this study we show that PAR3 al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arachiche, Amal, de la Fuente, María, Nieman, Marvin T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566007/ https://www.ncbi.nlm.nih.gov/pubmed/23405206 http://dx.doi.org/10.1371/journal.pone.0055740

Ejemplares similares

Correction: Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets
por: Arachiche, Amal, et al.
Publicado: (2013)

Platelet Specific Promoters Are Insufficient to Express Protease Activated Receptor 1 (PAR1) Transgene in Mouse Platelets
por: Arachiche, Amal, et al.
Publicado: (2014)

Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets
por: Han, Xu, et al.
Publicado: (2020)

Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets
por: French, Shauna L., et al.
Publicado: (2016)

Transcription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation
por: Saban, Ricardo, et al.
Publicado: (2007)

Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy
por: Rwibasira Rudinga, Gamariel, et al.
Publicado: (2018)

Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
por: Lin, Cong, et al.
Publicado: (2015)

MARK/Par1 Kinase Is Activated Downstream of NMDA Receptors through a PKA-Dependent Mechanism
por: Bernard, Laura P., et al.
Publicado: (2015)

Chemical Tools to Image the Activity of PAR-Cleaving Proteases
por: Lee, Irene Y., et al.
Publicado: (2023)

Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
por: Heuberger, Dorothea M., et al.
Publicado: (2019)

Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition
por: Meah, Mohammed N., et al.
Publicado: (2020)

Novel Role for Proteinase-activated Receptor 2 (PAR(2)) in Membrane Trafficking of Proteinase-activated Receptor 4 (PAR(4))
por: Cunningham, Margaret R., et al.
Publicado: (2012)

Correction to: protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
por: Heuberger, Dorothea M., et al.
Publicado: (2019)

PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
por: Wilson, Simon J., et al.
Publicado: (2018)

Par-4: A New Activator of Myosin Phosphatase
por: Vetterkind, Susanne, et al.
Publicado: (2010)

Long-term platelet priming after glycoprotein VI stimulation in comparison to Protease-Activating Receptor (PAR) stimulation
por: Zou, Jinmi, et al.
Publicado: (2021)

Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2)
por: Das, Mitali, et al.
Publicado: (2022)

Molecular cloning of the rat proteinase-activated receptor 4 (PAR4)
por: Hoogerwerf, Willemijntje A, et al.
Publicado: (2002)

Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2015)

Platelets differentially modulate CD4(+) Treg activation via GPIIa/IIIb-, fibrinogen-, and PAR4-dependent pathways
por: Bock, Matthias, et al.
Publicado: (2021)

CTP and parS coordinate ParB partition complex dynamics and ParA-ATPase activation for ParABS-mediated DNA partitioning
por: Taylor, James A, et al.
Publicado: (2021)

Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and Plasticity
por: Price, Rachel, et al.
Publicado: (2021)

Genetic Variant in Human PAR (Protease-Activated Receptor) 4 Enhances Thrombus Formation Resulting in Resistance to Antiplatelet Therapeutics
por: Tourdot, Benjamin E., et al.
Publicado: (2018)

Analysis of ParAB dynamics in mycobacteria shows active movement of ParB and differential inheritance of ParA
por: Uhía, Iria, et al.
Publicado: (2018)

Role of PAR-4 in ovarian cancer
por: Meynier, Sonia, et al.
Publicado: (2015)

PAR-4/Ca(2+)-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes
por: Giannella, Alessandra, et al.
Publicado: (2021)

Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer
por: Liu, Xuan, et al.
Publicado: (2017)

Predictive value of protease‐activated receptor‐2 (PAR(2)) in cervical cancer metastasis
por: He, Shengnan, et al.
Publicado: (2020)

Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity
por: Medipally, Ajay, et al.
Publicado: (2022)

Protease Activated Receptor 2 (PAR2) Induces Long-Term Depression in the Hippocampus through Transient Receptor Potential Vanilloid 4 (TRPV4)
por: Shavit-Stein, Efrat, et al.
Publicado: (2017)

Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1
por: De Simone, Ilaria, et al.
Publicado: (2022)

Par-4 prevents breast cancer recurrence
por: Hebbar, Nikhil, et al.
Publicado: (2013)

Protease-Activated Receptor (PAR)2, but Not PAR1, Is Involved in Collateral Formation and Anti-Inflammatory Monocyte Polarization in a Mouse Hind Limb Ischemia Model
por: van den Hengel, Lisa G., et al.
Publicado: (2013)

Negative cooperativity underlies dynamic assembly of the Par complex regulators Cdc42 and Par-3
por: Vargas, Elizabeth, et al.
Publicado: (2022)

Developmental Role of Zebrafish Protease-Activated Receptor 1 (PAR1) in the Cardio-Vascular System
por: Ellertsdottir, Elin, et al.
Publicado: (2012)

Discovery of 1,3-Diaminobenzenes as Selective Inhibitors of Platelet Activation at the PAR1 Receptor
por: Dockendorff, Chris, et al.
Publicado: (2012)

Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney Cells
por: Suen, Jacky Y., et al.
Publicado: (2010)

Feedback regulation of TORC1 by its downstream effectors Npr1 and Par32
por: Varlakhanova, Natalia V., et al.
Publicado: (2018)

Protease‐activated receptors: An illustrated review
por: Han, Xu, et al.
Publicado: (2020)

The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes
por: Denorme, Frederik, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k8d61crki6ocsnaa9oo2f2rl64